Management of the pregnant inflammatory bowel disease patient on anti-tumour necrosis factor: state of the art and future directions
{{output}}
Antitumour necrosis factor (anti-TNF) therapy has been a major advance in the treatment of inflammatory bowel disease (IBD) by improving rates of mucosal healing, steroid-free remission, and decreasing rates of hospitalization and surgery. Because IBD affects ... ...
